Metrizamide cisternography in the evaluation of pituitary adenomas and the empty sella syndrome.
D000238:Adenoma, Chromophobe / Q000000981:diagnostic imaging*; D000328:Adult; D004341:Drug Evaluation; D004652:Empty Sella Syndrome / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D008297:Male; D008722:Methods; D008793:Metrizamide / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000000981:diagnostic imaging*; D014056:Tomography, X-Ray / Q000379:methods*; D014057:Tomography, X-Ray Computed
D008793:Metrizamide